Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - glufosinate-ammonium - aqueous concentrate - glufosinate-ammonium organophosphorus-phosphinic ac active 200.0 g/l - herbicide - avocado | banana | blackberry | boysenberry | cane berry fruit | citrus fruit orchard | commercial area - general | feijoa | gua - amaranth or amaranthus | annual ryegrass | apple-of-peru | argentine peppercress | awnless barnyard grass | barley grass | barnyard or water grass | billygoat weed or blue top | bittercress or swinecress | black bindweed | bladder ketmia | blady grass | bordered panic | brome grass | calopo | caltrop or yellow vine | cape tulip | capeweed | centro | clover glycine | cobbler's pegs | common sida | common storksbill | couch grass | cowpea | crowsfoot grass | deadnettle | dwarf crumbweed | fat hen | foxtail millet | fumitory | giant sensitive plant | green crumbweed | greenleaf desmodium | hedge or wild mustard | johnson grass | lesser canary grass | liverseed or urochloa grass | medic | mintweed | new zealand spinach | panic | paspalum spp. | paterson's curse | perennial weed | pigweed spp. | pinkburr | potato or yellow weed | prairie grass | prickly lettuce | primocane control | red natal grass | saffron thistle | sago weed | scarlet or red pimpernel | shamrock | silver grass or rat's-tail fescue | silverleaf

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

grochem australia pty ltd - copper present as copper oxychloride - wettable powder - copper present as copper oxychloride mineral-copper active 500.0 g/kg - fungicide - almond | apricot | avocado | banana | blackcurrant | brassica vegetables | capsicum or pepper | carnation | carrot | celery | ci - algae | algal leaf spot | algal spot | angular leaf spot - p. griseola | angular leaf spot on cucurbit | anthracnose | anthracnose husk rot | ascochyta blight | bacterial black spot | bacterial blight | bacterial brown spot | bacterial canker | bacterial gummosis | bacterial leaf spot | bacterial speck | bacterial spot | black spot | black spot - guignardia citricarpa | blossom blight - sclerotinia fructicola | brown rot | brown spot - alternaria alternata | brown spot on passionfruit | cercospora leaf spot | chocolate spot on bean | citrus melanose | citrus scab | collar rot - phytophthora spp. | common blight | crown rot | dieback or canker | downy mildew | early blight | freckle | fungus | gummy stem blight on cucurbit | halo blight | husk spot - cercoseptoria spp. | late blight or irish blight | late or irish blight on tomato or potato | leaf curl | leaf scorch | leaf spot | lichen | masasso spot | parasitic algae on lychee | peppery leaf spot | phytophthora blight | phytophthora root rot | pink disease o

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

basf australia ltd. - glufosinate-ammonium - soluble concentrate - glufosinate-ammonium organophosphorus-phosphinic ac active 200.0 g/l - herbicide - avocado plantation | banana plantation | barley | blackberry | boysenberry | cane berry fruit | canola | cereal grain | chickpea - amaranth or amaranthus | annual or wimmera ryegrass | apple-of-peru | argentine peppercress | awnless barnyard grass | barley grass | barnyard grass or water grass | bellvine | billygoat weed or blue top | bindweed | black bindweed | bladder ketmia | blady grass | bordered panic | brome grass | calopo | caltrop or yellow vine | cape tulip | capeweed | centro | clammy goosefoot | clover glycine | cobbler's pegs | common bittercress or flickweed | common fumitory | common storksbill | couch grass | cowpea | crowsfoot grass | deadnettle | dwarf amaranth or boggabri weed | fat hen | field bindweed | flaxleaf fleabane | foxtail millet | green crumbweed | greenleaf desmodium | indian hedge mustard | johnson grass | lesser canary grass | liverseed or urochloa grass | medic | mimosa invisa | mintweed | new zealand spinach | noogoora burr complex - suppression of | paddy melon | panic | paspalum spp. | paterson's curse | peach vine | perennial pigweed | pigweed spp. | pink shamrock | pinkburr | pinus spp. - regenerati

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - light liquid paraffin; lanolin anhydrous; white soft paraffin - cream - 14.5%w/w +12.6%w/w+1.0 percent weight/weight - other emollients and protectives

Ireland - English - HPRA (Health Products Regulatory Authority)

leo laboratories limited - tinzaparin sodium - solution for injection - 14,000 iu/ 0.7 ml international unit(s)/millilitre - heparin group; tinzaparin

Singapore - English - HSA (Health Sciences Authority)

leo pharma asia pte ltd - tinzaparin sodium - injection - 14,000 iu - tinzaparin sodium 14,000 iu

Singapore - English - HSA (Health Sciences Authority)

aenon pharmaceuticals sea pte. ltd. - japanese encephalitis virus strain sa₁₄-14-2 (inactivated) - injection, suspension - 6 μg/0.5 ml - japanese encephalitis virus strain sa₁₄-14-2 (inactivated) 6 μg/0.5 ml

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - itraconazole, quantity: 100 mg - capsule - excipient ingredients: hypromellose; macrogol 20000; sucrose; hydrolysed maize starch; titanium dioxide; purified water; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - apo-itraconazole indicated for use in adults for the treatment of: ? superficial dermatomycoses not responding to topical treatment. ? fungal keratitis which has failed to respond to topical treatment or where the disease is either progressing rapidly or is immediately sight threatening. ? pityriasis versicolor not responding to any other treatment. ? vulvovaginal candidiasis not responding to topical treatment. ? oral candidiasis in immunocompromised patients. ? onychomycosis caused by dermatophytes. ? systemic mycoses: - systemic aspergillosis, histoplasmosis, sporotrichosis. - treatment and maintenance therapy in aids patients with disseminated or chronic pulmonary histoplasmosis infection. - treatment of oropharyngeal and/or oesophageal candidiasis when first line systemic antifungal therapy is inappropriate or has proven ineffective. - treatment of non-invasive candidiasis in non-neutropenic patients when first-line systemic antifungal therapy is inappropriate or has proven ineffective. this may be due to underlying pathology, insensitivity of the pathogen or drug toxicity.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - itraconazole, quantity: 100 mg - capsule - excipient ingredients: hypromellose; macrogol 20000; sucrose; hydrolysed maize starch; titanium dioxide; purified water; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - itracap is indicated for use in adults for the treatment of: ? superficial dermatomycoses not responding to topical treatment. ? fungal keratitis which has failed to respond to topical treatment or where the disease is either progressing rapidly or is immediately sight threatening. ? pityriasis versicolor not responding to any other treatment. ? vulvovaginal candidiasis not responding to topical treatment. ? oral candidiasis in immunocompromised patients. ? onychomycosis caused by dermatophytes. ? systemic mycoses: - systemic aspergillosis, histoplasmosis, sporotrichosis. - treatment and maintenance therapy in aids patients with disseminated or chronic pulmonary histoplasmosis infection. - treatment of oropharyngeal and/or oesophageal candidiasis when first line systemic antifungal therapy is inappropriate or has proven ineffective. - treatment of non-invasive candidiasis in non-neutropenic patients when first-line systemic antifungal therapy is inappropriate or has proven ineffective. this may be due to underlying pathology, insensitivity of the pathogen or drug toxicity.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - itraconazole, quantity: 100 mg - capsule - excipient ingredients: hypromellose; macrogol 20000; sucrose; hydrolysed maize starch; titanium dioxide; purified water; gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - itranox is indicated for use in adults for the treatment of: ? superficial dermatomycoses not responding to topical treatment. ? fungal keratitis which has failed to respond to topical treatment or where the disease is either progressing rapidly or is immediately sight threatening. ? pityriasis versicolor not responding to any other treatment. ? vulvovaginal candidiasis not responding to topical treatment. ? oral candidiasis in immunocompromised patients. ? onychomycosis caused by dermatophytes. ? systemic mycoses: - systemic aspergillosis, histoplasmosis, sporotrichosis. - treatment and maintenance therapy in aids patients with disseminated or chronic pulmonary histoplasmosis infection. - treatment of oropharyngeal and/or oesophageal candidiasis when first line systemic antifungal therapy is inappropriate or has proven ineffective. - treatment of non-invasive candidiasis in non-neutropenic patients when first-line systemic antifungal therapy is inappropriate or has proven ineffective. this may be due to underlying pathology, insensitivity of the pathogen or drug toxicity.